These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24189710)

  • 41. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.
    Huang KC; Hsu SP; Yang CC; Ou-Yang P; Lee KT; Morisawa S; Otsubo K; Chien CT
    Nephrol Dial Transplant; 2010 Aug; 25(8):2730-7. PubMed ID: 20190245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
    Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
    J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
    Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
    Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism.
    Jiang TJ; Cao XL; Luan S; Cui WH; Qiu SH; Wang YC; Zhao CJ; Fu P
    Mol Med Rep; 2018 Feb; 17(2):2137-2144. PubMed ID: 29207121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
    Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
    Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
    Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
    Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.
    Ju S; Qiu H; Zhou X; Zhu B; Lv X; Huang X; Li J; Zhang Y; Liu L; Ge Y; Johnson DE; Ju S; Shu Y
    Cell Cycle; 2009 Aug; 8(16):2578-85. PubMed ID: 19597336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Liu Y; Yun X; Gao M; Yu Y; Li X
    Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD.
    Yang X; Huo B; Zhong X; Su W; Liu W; Li Y; He Z; Bai J
    COPD; 2017 Dec; 14(6):618-625. PubMed ID: 29166179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating regulatory T cells in patients with severe fever with thrombocytopenia syndrome.
    Yi X; Li W; Li H; Jie S
    Infect Dis (Lond); 2015 May; 47(5):294-301. PubMed ID: 25712790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo depletion of CD4+CD25+ regulatory T cells in cats.
    Smithberg SR; Fogle JE; Mexas AM; Reckling SK; Lankford SM; Tompkins MB; Dean GA
    J Immunol Methods; 2008 Jan; 329(1-2):81-91. PubMed ID: 17980384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T cell receptor beta chain (TCR-Vbeta) repertoire of circulating CD4(+) CD25(-), CD4(+) CD25(low) and CD4(+) CD25(high) T cells in patients with long-term renal allograft survival.
    Velásquez SY; Arias LF; García LF; Alvarez CM
    Transpl Int; 2010 Jan; 23(1):54-63. PubMed ID: 19694999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.